Gerhard Schänzle

617 total citations
10 papers, 453 citations indexed

About

Gerhard Schänzle is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Gerhard Schänzle has authored 10 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Molecular Biology and 2 papers in Organic Chemistry. Recurrent topics in Gerhard Schänzle's work include Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Gerhard Schänzle is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Gerhard Schänzle collaborates with scholars based in Germany, United Kingdom and Italy. Gerhard Schänzle's co-authors include Gerd Mikus, Klaus Eckhardt, Shuxia Li, Michel Eichelbaum, Susanne Ammon, Ute Hofmann, Shuxia Li, Daniel Bischoff, Michel Eichelbaum and Martin F. Fromm and has published in prestigious journals such as Pain, Journal of Pharmacology and Experimental Therapeutics and Drug Metabolism and Disposition.

In The Last Decade

Gerhard Schänzle

10 papers receiving 439 citations

Peers

Countries citing papers authored by Gerhard Schänzle

Since Specialization

Citations

This map shows the geographic impact of Gerhard Schänzle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Schänzle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Schänzle more than expected).

Fields of papers citing papers by Gerhard Schänzle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerhard Schänzle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Schänzle. The network helps show where Gerhard Schänzle may publish in the future.

Co-authorship network of co-authors of Gerhard Schänzle

This figure shows the co-authorship network connecting the top 25 collaborators of Gerhard Schänzle. A scholar is included among the top collaborators of Gerhard Schänzle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerhard Schänzle. Gerhard Schänzle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	BI 1291583: a novel selective inhibitor of cathepsin C with superior in vivo profile for the treatment of bronchiectasis 2023 ·Inflammation Research ·(unknown), Gerhard Schänzle, Gisela Schnapp, Viktor V. Vintonyak, Marc A. Grundl	14
2	The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents 2019 ·Journal of Pharmacology and Experimental Therapeutics ·Holger Rosenbrock, Riccardo Giovannini, Gerhard Schänzle, Eliza Koroś, Frank Runge, Holger Fuchs, (unknown), Klaus G. Reymann, Ulrich H. Schröder, Ernesto Fedele, Cornelia Dorner‐Ciossek	27
3	Quantitative Expression of Hepatobiliary Transporters and Functional Uptake of Substrates in Hepatic Two-Dimensional Sandwich Cultures: A Comparative Evaluation of Upcyte and Primary Human Hepatocytes 2017 ·Drug Metabolism and Disposition ·(unknown), (unknown), Akiko Matsui, Gerhard Schänzle, Daniel Bischoff, Roderich D. Süßmuth	18
4	Upcyte Human Hepatocytes: a Potent In Vitro Tool for the Prediction of Hepatic Clearance of Metabolically Stable Compounds 2015 ·Drug Metabolism and Disposition ·(unknown), Gerhard Schänzle, Daniel Bischoff, Roderich D. Süßmuth	27
5	In vitroglucuronidation of the angiotensin II receptor antagonist telmisartan in the cat: a comparison with other species 2012 ·Journal of Veterinary Pharmacology and Therapeutics ·Thomas Ebner, Gerhard Schänzle, Wilfried Weber, (unknown), Jonathan Elliott	13
6	An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunction 2010 ·Bioorganic & Medicinal Chemistry Letters ·Stephen P. East, (unknown), (unknown), Christian Eickmeier, Adam Flegg, Boris Ferger, Mark J. Gemkow, Ralf Heilker, Bastian Hengerer, (unknown), (unknown), Gerhard Schänzle, (unknown), John R. Scott, Mark Whittaker, (unknown), (unknown), Kai Gerlach	36
7	Synthesis of [²H₃]‐dextromethorphan and its major urinary metabolites [²H₃]‐dextrorphan and [²H₃]‐dextrorphan‐β‐glucuronide 2002 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Georg Heinkele, Gerhard Schänzle, Thomas E. Mürdter	7
8	Rapid, highly sensitive method for the determination of morphine and its metabolites in body fluids by liquid chromatography–mass spectrometry 1999 ·Journal of Chromatography B Biomedical Sciences and Applications ·Gerhard Schänzle, Shuxia Li, Gerd Mikus, Ute Hofmann	57
9	Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation 1998 ·Pain ·Klaus Eckhardt, Shuxia Li, Susanne Ammon, Gerhard Schänzle, Gerd Mikus, Michel Eichelbaum	186
10	Loss of analgesic effect of morphine due to coadministration of rifampin 1997 ·Pain ·Martin F. Fromm, Klaus Eckhardt, Shuxia Li, Gerhard Schänzle, Ute Hofmann, Gerd Mikus, Michel Eichelbaum	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact